13 Aug 08

Pfizer is recognised as being one of the strongest performing pharmaceutical companies in terms of sales, revenue growth, acquisitions, breadth of portfolio, product launches and pipeline developments. Pfizer's prominence is due to the company having nine blockbuster products, seven market leaders and strong products in all the major therapeutic categories. How can you compete with them? Which areas are the exposed in? Find out today in this new Visiongain report.
Mike Wood

13 Aug 08

This feature 'What is Acne?' is one of three features that focuses on the topic of skin conditions.
PharmiWeb Editor

27 Jun 08

Finally a comprehensive source for the very latest performance metrics and trend analysis on every key aspect of the new drug approval processThe US Drug Approval Trends and Yearbook 2006/2007!
Rachel Thompson

23 Jun 08

In recent years Negative Pressure Wound Therapy has revolutionised the way clinicians manage and treat a wide range of wounds, Negative Pressure Wound Therapy (NPWT) is a mechanical wound care treatment that uses controlled negative pressure to assist and accelerate wound healing (Bryant, R. 2000).
Kevin Mearns

17 Jun 08

Cimzia (certolizumab pegol) is the first and so far, only, PEGylated, Fc-Free, anti-tumour necrosis factor (TNF) alpha treatment in development for rheumatoid arthritis. Data presented at the Annual European Rheumatology Congress (EULAR) suggest that, in combination with methotrexate, Cimzia acts fast to significantly suppress disease activity, prevent structural damage to joints, preserve physical function and help patients continue working productively.
Olwen Glynn Owen - Pharmiweb Field reporter

12 Jun 08

Alzheimer disease (AD) is the third leading cause of death in recent times and with an unprecedented patient potential, this disease area attracts awareness from a broad base of stake holders. With the grey population being the single most influencial factor in driving the economic growth within this sector, Visiongain believes the real market of the AD industry still remains untapped.
PharmiWeb Editor

09 Jun 08

Of patients with lung cancer, 80 per cent have non-small cell lung cancer (NSCLC) and of those, 40 per cent are not diagnosed until their disease is advanced and has spread to other organ sites. Current targeted treatment has improved survival but is not suitable for all. Now a new trial, FLEX, shows adding the targeted therapy Erbitux (cetuximab) to chemotherapy increases survival for all types of NSCLC.
Olwen Glynn Owen - PharmiWeb.com Field Reporter

09 Jun 08

The 'Scanning New Horizons in Rheumatoid Arthritis' Media Briefing is an innovative global press event featuring presentations by internationally renowned experts: Professor Paul Emery, Professor Robert Moots and Professor Bengt Jansson.
Editor

06 Jun 08

The EU GMPs were updated this year in February. As a result, Risk Management is a regulatory requirement and ICH Q9 is now Annex 20. EU regulators have also indicated that ICH Q10 on Pharmaceutical Quality Systems will become Annex 21 to the GMPs in June 2008 – sometime this month!
Belinda Chow

06 Jun 08

Kidney cancer patients who receive treatment with the orally-administered tyrosine kinase inhibitor sunitinib (Sutent) are living twice as long as patients who receive only interferon alpha treatment, according to data from a Phase III study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Survival now exceeds two years.
Olwen Glynn Owen - Pharmiweb Field Reporter

29 May 08

10 simple points to remember when writing a great CV. Your CV is the first point of contact between you and a prospective new employer. It is unlikely that the reader will know anything about you except what’s in the CV – so try to see it from their perspective.
Gwyneth Holland

29 May 08

A great summary of points to remember when writing your job application covering letter. The main purpose of a covering letter is to present your CV in support of your job application. This may be obvious, but it’s surprising how many people appear to think that a covering letter needs to be long and complicated and somehow justify its own existence..
Gwyneth Holland

23 May 08

Susan Garfield has joined Bridgehead International as VP, Bridgehead USA Inc. and will head up the company’s Boston office. Susan is a market access, reimbursement and economics strategist, with an expertise in demand creation and advocacy.
Sandra Church

21 May 08

We have an enviable position of being visited by over 150,000 people each month looking for pharmaceutical news and jobs, and we need to satisfy their desire for content.
Mike Wood

21 May 08

A trip to the doctor is the start of a conversation that provides the link between our everyday lives and the medical profession. Each day in the UK more than a million conversations take place between doctors and patients. When governments, policy makers and others talk about healthcare, these conversations often fade into the background. But conversations are the foundation for our health, with enormous potential impact.
Editor

09 May 08

“By 2010, almost 50 percent of children in North America and 38 percent of those in the European Union will be overweight, research has found”. For pharmaceutical companies looking to target growing successful markets, the anti-obesity drug treatment market offers unique opportunities.
Nini Wei- Visiongain Ltd

09 May 08

The symptoms of IBS and coeliac disease can often be very similar as a result the diagnosis of coeliac disease can be delayed or missed and IBS is misdiagnosed. The new guidelines regarding the diagnosis of Irritable Bowel Syndrome (IBS) announced recently by the National Institute for Health and Clinical Excellence (NICE) could ensure this should no longer happen by introducing new diagnostic criteria, which ensures testing for coeliac disease should be undertaken before a final diagnosis o
Paul Newbon

06 May 08

Obesity is the heavy accumulation of fat in your body to such a degree that it rapidly increases your risk of diseases that can damage your health and knock years off your life, such as heart disease and diabetes.
pharmiweb editor

06 May 08

Philip Miles of Alchemy explains the ins and outs of the daily life for Medical Sales Reps.
Philip Miles

16 Apr 08

Despite the pressures, medical and healthcare businesses appear to be reacting bullishly to the credit crunch according to a new study released today. When asked if they had to start their business again in today’s economic climate, 78% of medical and healthcare businesses would do it all again tomorrow.
David Barrett

16 Apr 08

In 2007, blood diseases cost the US’s economy $114bn. In 2004, a reported 232,000 deaths in the US were due to anaemia, myeloproliferative and myelodysplastic disorders, bleeding disorders, white blood cell disorders and thrombosis collectively. From oxygen delivery to immunological defence to clotting, blood has vital physiological functions, and clear, expensive treatments.
Justyna Drozdzal

15 Apr 08

Why do some people have allergies and some not? And why has the prevalence of allergic disorders been increasing over the past century, especially in industrialised, developed countries?
Mike Wood

11 Apr 08

Which current or future therapies will drive the sleep disorders market from 2008 to 2018? What is the patient identification rate for each of the therapeutic areas? What is the present state of the disease awareness? What R&D opportunities exist for ‘new comers’? Which key companies are involved in the market?
Justyna Drozdzal

01 Apr 08

Forget sweat patches, VPLs and spots…a new survey commissioned by Kleenex® has found that it’s blowing your nose in public that causes us the most embarrassment! The survey of hay fever sufferers reveals that most people prefer a quiet sniff over a good nose blow when out and about. However, allergy specialists warn that the more discreet option actually makes symptoms worse.
Jasmine Richards

31 Mar 08

Asthma is a significant health problem. Acording to the National Asthma Campaign, the condition continues to grow, and in the UK an estimated 8 million people are diagnosed as having asthma, with 5 million people receiving treatment. The cost of asthma to the NHS is more than £850 million a year.
Mike Wood

31 Mar 08

ADVANCED COMMUNICATION TECHNIQUES FOR DELIVERING TARGETED MESSAGES AND DEVELOPING BRAND LOYALTY
Matt Milman

25 Mar 08

Bell Pottinger Group has formed Bell Pottinger Health, a new business dedicated to leading the expansion of its health franchise with Shipra Singh newly hired as Managing Director. Simultaneously the company has brought in a life science investor relations team led by Mike Wort.
Deborah Cockerill

22 Mar 08

While having a sales force that can deliver your company¡¦s message to physicians and other health care professionals is critical to effective performance, the true key to success is having a sales force that can adapt that message to the needs and preferences of those they call on. Wilson Learning¡¦s research shows that versatile salespeople can be over 50% more successful than their less adaptable counterparts. This was effectively demonstrated in a study with a large pharmaceutical company.
Natalie Barlow

12 Mar 08

Chiltern, a leading global research organization, is proud to announce that it won 4 ‘Pharmas’ at the PharmaTimes Clinical Researcher of the Year ceremony, including the coveted Clinical Department of the Year.
Peter Lewis

21 Feb 08

Bridgehead International Board Appointment – February 2008 Richard Wallace joins Bridgehead International Board
Sandra Church